Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017.

ABSTRACT: This cross-sectional study uses data from the Centers for Medicare & Medicaid Services to assess the use of professional society guideline-nonconcordant radiotherapy in patients at the end of life.

SUBMITTER: Santos PMG 

PROVIDER: S-EPMC8903107 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature